Biocon engages law firm for governance review after CBI arrests Ruchika Sharma1 July 2022 2:30 PM ISTNew Delhi: Drugmaker Biocon Ltd. has engaged an external law firm to do a comprehensive review of its governance processes involving consultants and...
Health Bulletin 22/June/2022 Roshni Dhar22 Jun 2022 5:32 PM ISTHere are the top health stories for the day:Now TDS on free Physician Samples, Doctors under Income Tax Net In what is going to bring a...
Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case Farhat Nasim22 Jun 2022 2:58 PM ISTNew Delhi: Brewing controversy, the Central Bureau of Investigation (CBI) alleged senior Central Drugs Standards Control Organisation (CDSCO)...
Joint Drugs Controller under CBI net for allegedly taking bribe to waive off clinical trial of Biocon's Insulin Aspart injection Ruchika Sharma21 Jun 2022 11:49 AM ISTDenying allegations, a Biocon Biologics spokesperson said, "All our product approvals are legitimate and backed by science and clinical data. Our...
Glasgow University inaugrates Mazumdar Shaw Advance Research Centre Ruchika Sharma10 Jun 2022 11:00 AM ISTBengaluru: The University of Glasgow has announced the official opening of the Mazumdar-Shaw Advanced Research Centre by the Nobel Laureate,...
Biocon Biologics gets CDSCO panel nod to import, manufacture Insulin Aspart Injection Dr. Divya Colin25 May 2022 4:23 PM ISTNew Delhi: Approving the waiver of Phase III clinical trial in the country, the Subject Expert Committee (SEC) functional under Central Drug Standard...
Biocon Biologics, Viatris launch cancer medicine Abevmy in Canada Ruchika Sharma20 May 2022 3:02 PM ISTAbevmy is a recombinant humanized monoclonal antibody that selectively binds to human vascular endothelial growth factor (VEGF) and neutralizes its...
Biocon profit declines by 4 percent to Rs 283 crore in Q4 Ruchika Sharma30 April 2022 9:00 AM ISTNew Delhi: Biocon on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31,...
Biocon profit declines by 4 percent to Rs 283 crore in Q4 Ruchika Sharma30 April 2022 9:00 AM ISTNew Delhi: Biocon on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31,...
Biocon Biologics bags Rs 689 crore contract for Insugen from Malaysian Govt Ruchika Sharma27 April 2022 2:53 PM ISTThe rh-Insulin formulations, Insugen-R, Insugen-N and lnsugen-30/70, are manufactured at Biocon Sdn. Bhd.'s Johor facility.
Biocon Biologics Inpremzia gets backing from EMA expert panel Ruchika Sharma2 April 2022 12:43 PM ISTInpremzia is a pre-mixed ready-to-use insulin for IV infusion for patients in hospital and other acute care settings.
Honour- Glasgow University research centre named after Biocon founders Ruchika Sharma30 March 2022 11:42 AM ISTThe USD 7.5 million donation was used to help fund the building of the Mazumdar-Shaw Advanced Research Centre and create a Professorial Chair, the...
